Eum et al. adjusted for many known potential confound- ers, as in any observational study, our results could be confounded by unmeasured vari- ables. Approximately 20% of subjects were lost to follow-up, which could introduce a potential source of selection bias if attrition was associated both with exposure and out- come. However, subjects not lost to follow-up did not have statistically different age-adjusted lead levels or QTc intervals from those sub- jects lost to follow-up (p = 0.80, 0.85, and 0.22 for difference of levels of tibia, patella, and QTc interval, respectively). We also could not assess effects among women because all of our subjects were men. Our study is the first longitudinal study to examine cumulative lead exposure and sub- sequent development of cardiac conduction disorders, including temporal changes in QTc interval and QRSc duration. The results sug- gest that low-level cumulative exposure to lead is associated with future cardiac conductivity dysfunction in the ventricular myocardium, as reflected in QT interval characteristics, a risk factor for sudden death (Chugh et al. 2009). These results suggest that people with higher bone lead are a susceptible group for cardiac dysfunction. Ref Rencs Ahnve S. 1985. Correction of the QT interval for heart rate: review of different formulas and the use of Bazett’s formula in myocardial infarction. Am Heart J 109(3 Pt 1):568–574. Arizona Center for Education and Research on Therapeutics. 2010. Torsades List: Drugs with a Risk of Torsades de Pointes and Possible Torsades List: Drugs with a Possible Risk of Torsades de Pointes. Available: http://www.azcert. org/medical-pros/drug-lists/bycategory.cfm [accessed 15 March 2011]. Aro AC, Todd AC, Amarasiriwardena C, Hu H. 1994. Improvements in the calibration of 109Cd K x-ray fluores- cence systems for measuring bone lead in vivo. Phys Med Biol 39(12):2263–2271. Bell B, Rose CL, Damon A. 1966. The Veterans Administration lon- gitudinal study of healthy aging. Gerontologist 6(4):179–184. Ben-David J, Zipes DP, Ayers GM, Pride HP. 1992. Canine left ventricular hypertrophy predisposes to ventricular tachycardia induction by phase 2 early afterdepolariza- tions after administration of BAY K 8644. J Am Coll Cardiol 20(7):1576–1584. Benoit SR, Mendelsohn AB, Nourjah P, Staffa JA, Graham DJ. 2005. Risk factors for prolonged QTc among U.S. adults: Third National Health and Nutrition Examination Survey. Eur J Cardiovasc Prev Rehabil 12(4):363–368. Cheng Y, Schwartz J, Vokonas PS, Weiss ST, Aro A, Hu H. 1998. Electrocardiographic conduction disturbances in asso- ciation with low-level lead exposure (the Normative Aging Study). Am J Cardiol 82(5):594–599. Chugh SS, Reinier K, Singh T, Uy-Evanado A, Socoteanu C, Lidsky TI, Schneider JS. 2003. Lead neurotoxicity in children: basic Peters D, et al. 2009. Determinants of prolonged QT inter- val and their contribution to sudden death risk in coronary artery disease: the Oregon Sudden Unexpected Death Study. Circulation 119(5):663–670. mechanisms and clinical correlates. Brain 126(Pt 1):5–19. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. 2006. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Crow RS, Hannan PJ, Folsom AR. 2003. Prognostic significance Lancet 367(9524):1747–1757. of corrected QT and corrected JT interval for incident coronary heart disease in a general population sample stratified by presence or absence of wide QRS complex: the ARIC Study with 13 years of follow-up. Circulation 108(16):1985–1989. Lustberg M, Silbergeld E. 2002. Blood lead levels and mortality. Arch Intern Med 162(21):2443–2449. Menke A, Muntner P, Batuman V, Silbergeld EK, Guallar E. 2006. Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among U.S. adults. Circulation 114(13):1388–1394. Dekker JM, Crow RS, Hannan PJ, Schouten EG, Folsom AR. Montanez A, Ruskin JN, Hebert PR, Lamas GA, Hennekens 2004. Heart rate-corrected QT interval prolongation pre- dicts risk of coronary heart disease in black and white middle-aged men and women: the ARIC study. J Am Coll Cardiol 43(4):565–571. CH. 2004. Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the pro- spective cohort studies. Arch Intern Med 164(9):943–948. Gatagonova TM. 1995a. Bioelectrical activity of the myocardium Navas-Acien A, Guallar E, Silbergeld EK, Rothenberg SJ. 2007. and cardiac pump function in workers engaged in lead production [in Russian]. Gig Sanit 3:16–19. Lead exposure and cardiovascular disease—a systematic review. Environ Health Perspect 115:472–482. Gatagonova TM. 1995b. Changes of regional hemodynamics Navas-Acien A, Schwartz BS, Rothenberg SJ, Hu H, in lead manufacturing workers [in Russian]. Gig Sanit 2:16–17. Silbergeld EK, Guallar E. 2008. Bone lead levels and blood pressure endpoints: a meta-analysis. Epidemiology Gatagonova TM. 1995c. Functional state of the cardiovascu- 19(3):496–504. lar system in workers employed in lead production [in Piotrowicz K, Zareba W, McNitt S, Moss AJ. 2007. Repolarization Russian]. Med Tr Prom Ekol 1:15–22. Gump BB, Stewart P, Reihman J, Lonky E, Darvill T, Matthews KA, et al. 2005. Prenatal and early childhood blood lead levels and cardiovascular functioning in 9(1/2)- year-old children. Neurotoxicol Teratol 27(4):655–665. duration in patients with conduction disturbances after myocardial infarction. Am J Cardiol 99(2):163–168. Prineas R, Crow R, Blackburn H. 1982. The Minnesota Code Manual of Electrocardiographic Findings. Littleton, MA:J. Wright. Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada- Rubulis A, Jensen J, Lundahl G, Tapanainen J, Bergfeldt L. 2006. Vera B. 2009. Deaths: final data for 2006. Natl Vital Stat Rep 57(14):1–134. Ischemia induces aggravation of baseline repolarization abnormalities in left ventricular hypertrophy: a deleterious Hu H, Rabinowitz M, Smith D. 1998. Bone lead as a biological interaction. J Appl Physiol 101(1):102–110. marker in epidemiologic studies of chronic toxicity: Schober SE, Mirel LB, Graubard BI, Brody DJ, Flegal KM. 2006. conceptual paradigms. Environ Health Perspect 106:1–8. Jain NB, Potula V, Schwartz J, Vokonas PS, Sparrow D, Wright RO, et al. 2007. Lead levels and ischemic heart disease in a prospective study of middle-aged and elderly men: the VA Normative Aging Study. Environ Health Blood lead levels and death from all causes, cardiovas- cular disease, and cancer: results from the NHANES III mortality study. Environ Health Perspect 114:1538–1541. Schwartz J. 1991. Lead, blood pressure, and cardiovascular disease in men and women. Environ Health Perspect Perspect 115:871–875. 91:71–75. Kang YJ. 2006. Cardiac hypertrophy: a risk factor for Shcherbak EA. 1988. Effect of microclimate heating and QT-prolongation and cardiac sudden death. Toxicol Pathol 34(1):58–66. occupational noise and their combination with lead aerosols on the incidence of cardiovascular diseases [in Kasperczyk S, Przywara-Chowaniec B, Kasperczyk A, Russian]. Gig Tr Prof Zabol 11:25–27. Rykaczewska-Czerwinska M, Wodniecki J, Birkner E, et al. 2005. Function of heart muscle in people chronically exposed to lead. Ann Agric Environ Med 12(2):207–210. Shih RA, Hu H, Weisskopf MG, Schwartz BS. 2007. Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead. Kim R, Aro A, Rotnitzky A, Amarasiriwardena C, Hu H. 1995. Environ Health Perspect 115:483–492. K x-ray fluorescence measurements of bone lead con- centration: the analysis of low-level data. Phys Med Biol Silver W, Rodriguez-Torres R. 1968. Electrocardiographic studies in children with lead poisoning. Pediatrics 40(9):1475–1485. 41(6):1124–1127. Kim R, Landrigan C, Mossmann P, Sparrow D, Hu H. 1997. Age Sroczynski J, Urbanska-Bonenberg L, Twardowska-Saucha K, and secular trends in bone lead levels in middle-aged and elderly men: 3-year longitudinal follow-up in the Normative Aging Study. Am J Epidemiol 146(7):586–591. Kopp SJ, Barron JT, Tow JP. 1988. Cardiovascular actions of lead and relationship to hypertension: a review. Environ Health Perspect 78:91–99. Bonkowska M. 1985. Health status of workers chronically exposed to lead [in Polish]. Pol Tyg Lek 40(8):221–223. Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, et al. 2006. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 47(2):362–367. Kowey PR, Friechling TD, Sewter J, Wu Y, Sokil A, Paul J, Vrtovec B, Sinkovec M, Starc V, Radovancevic B, Schlegel et al. 1991. Electrophysiological effects of left ventricular hypertrophy. Effect of calcium and potassium channel blockade. Circulation 83(6):2067–2075. TT. 2005. Coronary artery disease alters ventricular repolarization dynamics in type 2 diabetes. Pacing Clin Electrophysiol 28(suppl 1):S178–S181. Kristal-Boneh E, Coller D, Froom P, Harari G, Ribak J. 1999. Weisskopf MG, Jain N, Nie H, Sparrow D, Vokonas P, The association between occupational lead exposure and serum cholesterol and lipoprotein levels. Am J Public Health 89(7):1083–1087. Krotkiewski A, Juskowa J, Koziolowa H. 1964. Electrocardiographic changes in patients with lead poisoning [in Polish]. Pol Arch Med Wewn 34:1223–1228. Schwartz J, et al. 2009. A prospective study of bone lead concentration and death from all causes, cardiovascular diseases, and cancer in the Department of Veterans Affairs Normative Aging Study. Circulation 120(12):1056–1064. 944 ovlume 119 | number 7 | July 2011 • Environmental Health Perspectives